email@mymsaa.org
Multiple Sclerosis Association of America Logo
Link to FaceBook Link to Twitter Link to YouTube Link to Pinterest
Improving Lives Today!
donate
About MS
MS Overview
Newly Diagnosed
Symptoms
Treatments
Online Webinars & Videos
MSAA Publications
Prescription Assistance Programs
Toll-Free Helpline
Clinical Trial Information
Información en Español
FAQs



Home > About MS > Clinical Trials Resource Center


Therapeutic Areas: Neurology | Musculoskeletal | Family Medicine

Multiple Sclerosis Clinical Trials


A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : Alabama Neurology Associates

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis

Birmingham : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Birmingham : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Birmingham : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Birmingham : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Birmingham : University of Alabama at Birmingham

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Cullman : Investigational Site Number 840004

A clinical trial to evaluate treatments using Vatelizumab SAR339658 for patients with Relapsing-remitting Multiple Sclerosis

Cullman : Investigational Site Number 840004

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Cullman : Teva Investigational Site 10329 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Cullman : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Arizona

Gilbert : Neurological Physicians of Arizona/Clinical Research Advantage

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Gilbert : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Gilbert : Neurological Physicians of Arizona/Clinical Research Advantage

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Glendale : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Phoenix : HOPE Research Institute Updated

A clinical research study of Blood Draw and CSF collection by lumbar puncture (Optional) for the treatment of Secondary Progressive Multiple Sclerosis

Phoenix : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Phoenix : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Phoenix : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Phoenix : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Phoenix : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Phoenix : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Phoenix : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Tempe : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Tucson : NNS Clinical Research, LLC

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Tucson : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Tucson : Northwest NeuroSpecialists, PLLC

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Tucson : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Tucson : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Tucson : NNS Clinical Research, LLC

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Tucson : Northwest NeuroSpecialists, PLLC

Patients are needed to participate in a clinical research study of MSDX Complex-1 Biomarker test to evaluate Relapsing Remitting Multiple Sclerosis

California

Berkeley : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Berkeley : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Davis : University of California Davis

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Fresno : Victoria Walton, MD

A clinical study for patients with Multiple Sclerosis

Fresno : Teva Investigational Site 10310 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Fullerton : Fullerton Neurology and Headache Center

A clinical study for patients with Multiple Sclerosis

Fullerton : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Fullerton : Fullerton Neurology and Headache Center

Patients are needed to participate in a clinical research study of Natalizumab to evaluate Relapsing Multiple Sclerosis

La Jolla : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

La Jolla : StemGenex

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis

Loma Linda : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Long Beach : Collaborative Neuroscience Network, Inc.

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Los Angeles : Sanguine Biosciences

A clinical study for patients with Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease or Huntington's Disease

Los Angeles : Keck School of Medicine of the University of Southern Calfornia

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Los Angeles : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Los Angeles : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Los Angeles : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Los Angeles : Sanguine Biosciences

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Los Angeles : Univeristy of California Los Angeles

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Newport Beach : Multiple Sclerosis Center of California & Research

A clinical study for patients with Multiple Sclerosis

Newport Beach : MS Center of California

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Newport Beach : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Newport Beach : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Newport Beach : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Newport Beach : MS Center of California

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Oceanside : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Oceanside : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Rancho Mirage : California Stem Cell Treatment Center

A clinical trial to evaluate treatments using Administration of autologous adipose derived SVF

Sacramento : Sutter Institute for Medical Research

A clinical study for patients with Multiple Sclerosis

Sacramento : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Sacramento : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Sacramento : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Sacramento : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sacramento : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sacramento : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

San Diego : Pacific Research Network Inc

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

San Diego : Novartis Investigative Site

A clinical research study of VAY736 and Placebo for the treatment of Relapse Remitting Multiple Sclerosis

San Francisco : University of California San Francisco

A clinical study for patients with Multiple Sclerosis

San Francisco : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

San Francisco : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Temecula : Viking Clinical Research Center

A clinical study for patients with Multiple Sclerosis

Torrance : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Torrance : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Torrance : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Colorado

Boulder : Alpine Clinical Research Center

Investigational Medication for people with Relapsing Remitting Multiple Sclerosis

Boulder : Alpine Clinical Research Center

New Investigational Medication for Relapsing Remitting Multiple Sclerosis (RRMS)

Boulder : Alpine Clinical Research Center

New Investigational Medication for Relapsing Remitting Multiple Sclerosis (RRMS) who have had a documented relapse in the last year

Boulder : Alpine Clinical Research Center

New Investigational Medication for Secondary Progressive Multiple Sclerosis

Boulder : Alpine Clinical Research Center

Newly Approved Medication for Multiple Sclerosis

Aurora : University of Colorado Updated

A clinical research study of Blood Draw and CSF collection by lumbar puncture (Optional) for the treatment of Secondary Progressive Multiple Sclerosis

Aurora : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Aurora : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Aurora : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Aurora : University of Colorado Denver

A clinical trial to evaluate treatments using ACTHAR Gel (ACTH) and IV steroids with oral taper for patients with Multiple Sclerosis

Aurora : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Aurora : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Aurora : Teva Investigational Site 10307 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Aurora : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Basalt : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Centennial : Investigational Site Number 840006

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Colorado Springs : Research Site

A clinical trial to evaluate treatments using natalizumab and fingolimod for patients with Relapsing-Remitting Multiple Sclerosis

Colorado Springs : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Denver : Mountain View Clinical Research, Inc.

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Denver : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Denver : Mountain View Clinical Research, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Denver : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Denver : University of Colorado Denver

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Englewood : Colorado Neurological Institute

A clinical study for patients with Multiple Sclerosis

Englewood : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Englewood : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Fort Collins : Advanced Neurosciences Research, LLC

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Fort Collins : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Fort Collins : Investigational Site Number 840005

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Fort Collins : Teva Investigational Site 10332 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Fort Collins : Advanced Neurosciences Research, LLC

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Fort Collins : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Connecticut

Danbury : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Danbury : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Derby : Multiple Sclerosis Treatment Center

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Derby : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Derby : Multiple Sclerosis Treatment Center

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Fairfield : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Fairfield : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Hartford : The Mandell Center for Multiple Sclerosis

Patients are needed to participate in a clinical research study evaluating Avonex for the treatment of Multiple Sclerosis

New Haven : Institute for Neurodegenerative Disorders

Patients are needed to participate in a clinical research study of [18F]Florbetapir and PET imaging to evaluate Multiple Sclerosis

New London : Coastal Connecticute Research, LLC

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

New London : Coastal Connecticute Research, LLC

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

North Haven : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Delaware

Dover : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Dover : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Dover : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Newark : Christiana Care Health Services

A clinical study for patients with Multiple Sclerosis

Newark : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Newark : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Newark : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

District of Columbia

Washington : Georgetown University Hospital

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Washington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Washington : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Washington : Georgetown University Hospital

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Washington : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Florida

Tampa : Axiom Clinical Research of Florida

A 12-month, Prospective, Randomized, Active-controlled, Open-label Study to Evaluate the Patient Retention of Fingolimod vs. Approved First-line Disease Modifying Therapies in Adults Who Are in Early Stages of Treatment for Relapsing Remitting Multiple Sclerosis

Tampa : Axiom Clinical Research of Florida

A 12-month, Randomized, Rater- and Dose-blinded Study to Compare the Efficacy and Safety of Fingolimod 0.25 mg and 0.5 mg Administered Orally Once Daily With Glatiramer Acetate 20 mg Administered Subcutaneously Once Daily in Patients With Relapsing-remitting Multiple Sclerosis

Tampa : University of South Florida - Morsani Center for Advance Healthcare

A Clinical Evaluation of the Safety of Baclofen ER Capsules (GRS) When Administered Once Daily to Subjects with Spasticity due to Multiple Sclerosis (MS): An Open Label, Long Term, Safety Trial

Tampa : University of South Florida - Morsani Center for Advance Healthcare

A Multicenter, Global, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfidera™ (Dimethyl Fumarate) When Used in Routine Medical Practice in the Treatment of Multiple Sclerosis (ESTEEM)

Tampa : University of South Florida - Morsani Center for Advance Healthcare

A Multicenter, Open-Label, 12-Month Observational Study Evaluating the Clinical Effectiveness and Impact on Patient-Reported Outcomes of Oral Tecfidera™ (dimethyl fumarate) Delayed-Release Capsules in Patients With Relapsing Forms of Multiple Sclerosis After Suboptimal Response to Glatiramer Acetate

Tampa : University of South Florida - Morsani Center for Advance Healthcare

A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Long-Term Efficacy and Safety of Prolonged Release Fampridine (BIIB041) 10 mg, Administered Twice Daily in Subjects With Multiple Sclerosis

Tampa : University of South Florida - Morsani Center for Advance Healthcare

A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled Variable Treatment Duration Study Evaluating the Efficacy and Safety of Siponimod (BAF312) in Patients With Secondary Progressive Multiple Sclerosis.

Tampa : University of South Florida - Morsani Center for Advance Healthcare

A Multicenter, Retrospective, Observational Study Evaluating Real-world Clinical Outcomes in Relapsing-remitting Multiple Sclerosis Patients Who Transition From Tysabri® (Natalizumab) to Tecfidera® (Dimethyl Fumarate)

Tampa : University of South Florida - Morsani Center for Advance Healthcare

A Placebo-controlled Randomized Withdrawal Evaluation of the Efficacy and Safety of Baclofen ER Capsules (GRS) in Subjects With Spasticity Due to Multiple Sclerosis

Tampa : University of South Florida - Morsani Center for Advance Healthcare

A Single-center Prospective Measurement of Adherence to Treatment With Tecfidera™ in Multiple Sclerosis Patients.

Tampa : Axiom Clinical Research of Florida

An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing Arbaclofen Placarbil Safety in Subjects With Spasticity Associated With Multiple Sclerosis

Tampa : Meridien Research

Multiple Sclerosis Medication Study

Tampa : Meridien Research

Multiple Sclerosis Medication Study

Tampa : Meridien Research

Multiple Sclerosis Medication Study

Tampa : Meridien Research

Oral Multiple Sclerosis Medication Study

Bradenton : Brandenton Neurology, Inc.

A clinical study for patients with Multiple Sclerosis

Bradenton : Bradenton Research Center, Inc.

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Bradenton : Bradenton Research Center, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Delray Beach : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Gainesville : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Hollywood : Sunrise Clinical Research, Inc.

A clinical study for patients with Multiple Sclerosis

Jacksonville : University of Florida

A clinical study for patients with Multiple Sclerosis

Jacksonville : Jacksonville Center For Clinical Research

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Jacksonville : University of Florida Health Science Center

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Jacksonville : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Jacksonville : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Jacksonville : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Jacksonville : University of Florida Health Science Center

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Jacksonville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Lighthouse Point : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Lighthouse Point : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Maitland : Neurology Associates, PA

A clinical study for patients with Multiple Sclerosis

Maitland : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Maitland : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Maitland : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Maitland : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Miami : University of Miami/Miller School of Medicine

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Miami : University of Miami Miller School of Medicine

A clinical research study of Electrical impedance myography (EIM) for the treatment of Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Charcot-Marie-Tooth Disease or Multiple Sclerosis

Miami : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Miami : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Miami : University of Miami Miller School of Medicine

A Phase 2 clinical study for patients with Relapsing Remitting MS, Secondary Progressive MS or Primary Progressive MS

Miami : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Miami : Teva Investigational Site 10316 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Miami : University of Miami/Miller School of Medicine

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Miami : University of Miami Miller School of Medicine

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Miami Springs : Ocean Blue Medical Research Center Inc

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Orlando : Compass Research

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Orlando : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Ormond Beach : Neurology Associates of Ormond Beach

A clinical study for patients with Multiple Sclerosis

Ormond Beach : Neurology Associates of Ormond Beach

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Ormond Beach : Receptos Study Site 135 Updated

A clinical trial to evaluate treatments using RPC1063 and Beta interferon for patients with Multiple Sclerosis

Ormond Beach : Investigational Site Number 840007

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Ormond Beach : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ormond Beach : Neurology Associates of Ormond Beach

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Ormond Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Pompano Beach : Neurological Associates

A clinical study for patients with Multiple Sclerosis

Pompano Beach : Infinity Clinical Research, LLC

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Pompano Beach : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Pompano Beach : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Pompano Beach : Infinity Clinical Research, LLC

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Pompano Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Port Charlotte : Neurostudies, Inc.

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Port Charlotte : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Port Charlotte : Neurostudies, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Port Charlotte : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Port Orange : Progressive Medical Research

A clinical study for patients with Multiple Sclerosis

Sarasota : Roskamp Institute

A clinical study for patients with Multiple Sclerosis

Sarasota : Lovelace Scientific Resources, Inc.

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Sarasota : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Sarasota : Teva Investigational Site 10308 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sarasota : Lovelace Scientific Resources, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Sarasota : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Sarasota : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

St. Petersburg : Suncoast Neuroscience Associates, Inc

A clinical study for patients with Multiple Sclerosis

St. Petersburg : Suncoast Neuroscience Associates Inc

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

St. Petersburg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

St. Petersburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sunrise : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tallahassee : AMO Corporation

A clinical study for patients with Multiple Sclerosis

Tallahassee : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tallahassee : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Tallahassee : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Tampa : University of South Florida

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Tampa : USF Carol and Frank Morsani Center for Advanced Healthcare

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Tampa : Research site

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Tampa : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Tampa : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Tampa : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tampa : Receptos Study Site 147 Updated

A clinical trial to evaluate treatments using RPC1063 and Beta interferon for patients with Multiple Sclerosis

Tampa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tampa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tampa : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Tampa : University of South Florida

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Tampa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Vero Beach : MS Center of Vero Beach

A clinical study for patients with Multiple Sclerosis

Vero Beach : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Vero Beach : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Vero Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

West Palm Beach : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Weston : Cleveland Clinic Florida

A clinical study for patients with Multiple Sclerosis

Georgia

Atlanta : NeuroTrials Research

Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.

Atlanta : Emory University

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Atlanta : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Atlanta : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Atlanta : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Atlanta : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Atlanta : Emory University

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Atlanta : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Atlanta : Emory University

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Atlanta : MS Center of Atlanta

Patients are needed to participate in a clinical research study of Natalizumab to evaluate Relapsing Multiple Sclerosis

Decatur : Neurostudies

A clinical study for patients with Multiple Sclerosis

Douglasville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Savannah : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Hawaii

Honolulu : Leo Maher, MD

A clinical study for patients with Multiple Sclerosis

Illinois

Elk Grove Village : Alexian Brothers Hospital Network

A 6 month, randomized, active comparator, open-label, multi-center study to evaluate patient outcomes, safety and tolerability of Fingolimod (FTY720) 0.5mg/day in patients with relapsing remitting MS who are candidates for MS therapy change from previous disease modifying therapy (EPOC).

Barrington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Champaign : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Chicago : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Chicago : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Chicago : University of Chicago

Patients are needed to participate in a clinical research study evaluating Tysabri for the treatment of Multiple Sclerosis

Elk Grove Village : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Evanston : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Evanston : Northwestern University

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Flossmoor : South Suburban Neurology

A clinical study for patients with Multiple Sclerosis

Flossmoor : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Flossmoor : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Lake Barrington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Northbrook : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Peoria : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Peoria : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Indiana

Anderson : Community Clinical Research Center

A 12-month, Prospective, Randomized, Active-controlled, Open-label Study to Evaluate the Patient Retention of Fingolimod vs. Approved First-line Disease Modifying Therapies in Adults Who Are in Early Stages of Treatment for Relapsing Remitting Multiple Sclerosis (PREFERMS)

Elkhart : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Fort Wayne : Teva Investigational Site 10339 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Indianapolis : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Indianapolis : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Indianapolis : Investigational Site Number 840001

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Indianapolis : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Merrillville : Neuroscience Institute

A clinical study for patients with Multiple Sclerosis

Iowa

Des Moines : Mercy Ruan Neurology Clinic Res Ct.

A clinical study for patients with Multiple Sclerosis

Des Moines : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Des Moines : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

West Des Moines : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Kansas

Lenexa : MidAmerica Neuroscience Research Foundation DBA: Rowe Neurology Institute

A 12-month, randomized, rater- and dose-blinded study to compare the efficacy and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate 20 mg administered subcutaneously once daily in patients with relapsing-remitting multiple sclerosis

Lenexa : MidAmerica Neuroscience Research Foundation DBA: Rowe Neurology Institute

A clinical evaluation of the safety of baclofen ER capsules (GRS) when administered once daily to subjects with spasticity due to multiple sclerosis (MS): an open label, long term, safety trial

Lenexa : MidAmerica Neuroscience Research Foundation DBA: Rowe Neurology Institute

A double-blind, randomized, placebo-controlled, parallel group trial to evaluate the duration of action of baclofen ER capsules (GRS) in subjects with spasticity due to multiple sclerosis (MS)

Lenexa : MidAmerica Neuroscience Research Foundation DBA: Rowe Neurology Institute

A multicenter, global, observational study to collect information on safety and to document the drug utilization of tecfidera (dimethyl fumarate) when used in routine medical practice in the treatment of multiple sclerosis (ESTEEM)

Lenexa : MidAmerica Neuroscience Research Foundation DBA: Rowe Neurology Institute

A multicenter, open-label, 12-month observational study evaluating the clinical effectiveness and impact on patient-reported outcomes of oral tecfidera (dimethyl fumarate) delayed-release capsules in patients with relapsing forms of multiple sclerosis after suboptimal response to glatiramer acetate

Lenexa : MidAmerica Neuroscience Research Foundation DBA: Rowe Neurology Institute

A multicenter, randomized, double-blind, parallel-group, placebo-controlled variable treatment duration study evaluating the efficacy and safety of siponimod (BAF312) in patients with secondary progressive multiple sclerosis

Lenexa : MidAmerica Neuroscience Research Foundation DBA: Rowe Neurology Institute

A multicenter, randomized, double-blind, placebo-controlled, parallel-group, study comparing the efficacy and safety of two doses of subcutaneous LBR-101 with placebo for the preventative treatment of high frequency episodic migraine

Lenexa : MidAmerica Neuroscience Research Foundation DBA: Rowe Neurology Institute

A placebo-controlled randomized withdrawal evaluation of the efficacy and safety of baclofen ER capsules (GRS) in subjects with spasticity due to multiple sclerosis

Lenexa : MidAmerica Neuroscience Research Foundation DBA: Rowe Neurology Institute

Long-term, prospective, observational, multinational, parallel-cohort study monitoring safety in patients with MS newly started with fingolimod once daily or treated with another approved disease-modifying therapy

Kansas City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Kansas City : University of Kansas Medical Center

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Lenexa : Mid America Neuroscience Institute

A clinical study for patients with Multiple Sclerosis

Lenexa : Midamerica Neuroscience Institute - Rowe Neurology Institute

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Lenexa : Rowe Neurology Institute

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Lenexa : Rowe Neurology Institute Updated

A clinical research study of Blood Draw and CSF collection by lumbar puncture (Optional) for the treatment of Secondary Progressive Multiple Sclerosis

Lenexa : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Lenexa : Receptos Study Site 142 Updated

A clinical trial to evaluate treatments using RPC1063 and Beta interferon for patients with Multiple Sclerosis

Lenexa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Lenexa : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Lenexa : Teva Investigational Site 12969 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod and Placebo for the treatment of Primary Progressive Multiple Sclerosis

Lenexa : Rowe Neurology Institute

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Lenexa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Overland Park : Overland Park Surgical Specialties Neurology

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Overland Park : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Overland Park : Overland Park Surgical Specialties Neurology

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Topeka : Precise Clinical Research

A clinical study for patients with Multiple Sclerosis

Topeka : Cotton O'Neil Clinical Research Institute

A clinical study for patients with Multiple Sclerosis

Kentucky

Lexington : University of Kentucky Chandler Medical Center

Help us to make progress in Secondary Progressive MS

Henderson : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Lexington : Associates in Neurology

A clinical study for patients with Multiple Sclerosis

Lexington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Lexington : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Lexington : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Louisville : Norton Healthcare, Inc.

A clinical study for patients with Multiple Sclerosis

Louisville : Norton Neurology MS Services

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Louisville : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Louisville : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Louisville : Norton Neurology MS Services

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Louisville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Louisiana

Baton Rouge : The Neuromedical Center Clinic

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Baton Rouge : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Baton Rouge : The Neuromedical Center Clinic

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Hammond : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Hammond : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

New Orleans : Ochsner/Baptist Clinic Foundation

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

New Orleans : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

New Orleans : Ochsner/Baptist Clinic Foundation

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

New Orleans : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Maine

Rockport : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Maryland

Annapolis : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Baltimore : University of Maryland

A clinical study for patients with Multiple Sclerosis

Baltimore : Johns Hopkins

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Baltimore : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Baltimore : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Baltimore : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Baltimore : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Baltimore : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Baltimore : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Baltimore : Johns Hopkins

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Bethesda : Bethesda Neurology, LLC

A clinical study for patients with Multiple Sclerosis

Bethesda : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Bismarck : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Fulton : Maryland Pain and Spine Center, LLC

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Fulton : Maryland Pain and Spine Center, LLC

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Washington DC : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Massachusetts

Boston : Caritas St. Elizabeth's Hospital

A clinical study for patients with Multiple Sclerosis

Boston : Massachusetts General Hospital

A clinical research study of Electrical impedance myography (EIM) for the treatment of Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Charcot-Marie-Tooth Disease or Multiple Sclerosis

Boston : Skulpt, Inc

A clinical research study of Electrical impedance myography (EIM) for the treatment of Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Charcot-Marie-Tooth Disease or Multiple Sclerosis

Boston : Call EMD Serono Medical Information for information on recruiting sites

A clinical research study of Rebif® for the treatment of Multiple Sclerosis

Boston : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Boston : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Boston : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Boston : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Boston : Teva Investigational Site 10338 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Boston : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Boston : Brigham and Women's Hospital

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Boston : Massachusetts General Hospital

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Cambridge : Outcome Sciences, Inc

A clinical trial to evaluate treatments using Cladribine for patients with Multiple Sclerosis

Cambridge : Novartis Investigative Site

Patients are needed to participate in a clinical research study of Fingolimod to evaluate Multiple Sclerosis

Foxboro : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Lexington : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Lexington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Lexington : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Milford : Milford Regional Medical Center

A clinical study for patients with Multiple Sclerosis

Springfield : Springfield Neurology Associates, LLC

A clinical study for patients with Multiple Sclerosis

Springfield : Springfield Neurology Associates

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Springfield : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Springfield : Springfield Neurology Associates

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Springfield : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Worcester : Fallon Clinic at Worcester Medical Center

A clinical study for patients with Multiple Sclerosis

Worcester : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Worcester : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Michigan

Kalamazoo : Bronson Methodist Hospital

A 12-month, Prospective, Randomized, active-controlled, open-label study to Evaluate the patient retention of Fingolimod vs. approved first-line disease modifying therapies in adults who are in Early stages of treatment for Relapsing remitting multiple sclerosis (PREFERMS)

Ann Arbor : University of Michigan Health System -Multiple Sclerosis Center Updated

A clinical research study of Blood Draw and CSF collection by lumbar puncture (Optional) for the treatment of Secondary Progressive Multiple Sclerosis

Ann Arbor : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ann Arbor : University of Michigan Health Systems

Patients are needed to participate in a clinical research study of SoluMedrol and Extracorporeal Photopheresis to evaluate Secondary Progressive Multiple Sclerosis

Bingham Farms : Quest Research Institute

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Clinton Township : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Detroit : Henry Ford Health System, Department of Neurology

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Detroit : Henry Ford Health System Updated

A clinical research study of Blood Draw and CSF collection by lumbar puncture (Optional) for the treatment of Secondary Progressive Multiple Sclerosis

Detroit : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Detroit : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Detroit : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Detroit : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Detroit : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Detroit : Henry Ford Health System, Department of Neurology

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Detroit : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

East Lansing : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

East Lansing : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Grand Rapids : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Grand Rapids : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Muskegon : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Minnesota

Edina : Minneapolis Clinic of Neurology

A clinical study for patients with Multiple Sclerosis

Edina : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Golden Valley : Minneapolis Clinic of Neurology

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Golden Valley : Minneapolis Clinic of Neurology Updated

A clinical research study of Blood Draw and CSF collection by lumbar puncture (Optional) for the treatment of Secondary Progressive Multiple Sclerosis

Golden Valley : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Golden Valley : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Golden Valley : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Golden Valley : Minneapolis Clinic of Neurology

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Minneapolis : Clinical Neuroscience Research Unit, University of Minnesota

A clinical trial seeking patients for a research study for the treatment of Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis or Progressive Relapsing Multiple Sclerosis

Mississippi

Ocean Springs : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Missouri

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Children with and without Multiple Sclerosis or (MS) or Clinically Isolated Syndrome (CIS) are needed for a Washington University research study.

Columbia : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Kansas City : Saint Luke's Hospital

A clinical study for patients with Multiple Sclerosis

Kansas City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Springfield : St.John's Research Institute, Inc

A clinical study for patients with Multiple Sclerosis

St. Louis : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

St. Louis : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

St. Louis : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

St. Louis : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

St. Louis : Washington University School of Medicine in St Louis

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

St. Louis : Washington University

Patients are needed to participate in a clinical research study of Natalizumab to evaluate Relapsing Multiple Sclerosis

Montana

Great Falls : Benefis Physician Associates

A clinical study for patients with Multiple Sclerosis

Great Falls : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Great Falls : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Nebraska

Lincoln : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Lincoln : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Lincoln : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Omaha : University of Nebraska Medical Center (UNMC) Neurological Sciences

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Omaha : University of Nebraska Medical Center (UNMC) Neurological Sciences

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Nevada

Las Vegas : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

New Hampshire

Lebanon : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Lebanon : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

New Jersey

Freehold : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Freehold : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Freehold : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Newark : UMDNJ

A clinical study for patients with Multiple Sclerosis

Newark : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Princeton : GE Healthcare

A Phase 1 clinical study for patients with Evaluate the Safety of GEH120714 (18F) Injection in Healthy Volunteers (HV) and Participants With rrMS.

Stratford : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Teaneck : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Toms River : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

New Mexico

Albuquerque : Lovelace Scientific Resources, Inc.

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Albuquerque : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Albuquerque : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Albuquerque : Lovelace Scientific Resources, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Albuquerque : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

New York

Mineola : Winthrop University Hospital Clinical Trials Center

Multiple Sclerosis - (MS) Primary Progressive Multiple Sclerosis

Albany : Neurological Associates of Albany, PC

A clinical study for patients with Multiple Sclerosis

Albany : Albany Advanced Imaging

A clinical trial to evaluate treatments for patients with Multiple Sclerosis (MS)

Albany : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Amherst : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Amherst : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Bronx : Montefiore Medical Center

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Buffalo : Buffalo Neuroimaging Analysis Center

A clinical research study for the treatment of Multiple Sclerosis

Buffalo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Buffalo : University at Buffalo, The State University of New York

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

East Meadow : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Kingston : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Latham : Empire Neurology, PC

A clinical study for patients with Multiple Sclerosis

Latham : Multiple Sclerosis Center of Northeastern New York

A clinical research study of incabotulinumtoxinA and Placebo for the treatment of Muscle Spasticity or Multiple Sclerosis

Latham : Northeast Eye Center

A clinical trial to evaluate treatments for patients with Multiple Sclerosis (MS)

Latham : Fallon Wellness Pharmacy

A clinical trial to evaluate treatments for patients with Multiple Sclerosis (MS)

Latham : The MS Center of Northeastern New York

A clinical trial to evaluate treatments for patients with Multiple Sclerosis (MS)

Latham : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Latham : Investigational Site Number 840001

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Mineola : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

New York : Research Site

A clinical research study of BG00002 (Natalizumab) and BG00012 (dimethyl fumarate) for the treatment of Relapsing-Remitting Multiple Sclerosis

New York : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

New York : Weill Cornell Medical College

A clinical trial seeking patients for a research study for the treatment of Secondary Progressive Multiple Sclerosis

New York : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

New York : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

New York : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

New York : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

New York : Icahn School of Medicine at Mount Sinai

Patients are needed to participate in a clinical research study evaluating Acthar Gel for the treatment of Multiple Sclerosis

New York : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

New York : Cornell Medical College

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

New York : Columbia University Medical Center

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Patchogue : South Shore Neurologic Associates

A clinical study for patients with Multiple Sclerosis

Patchogue : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Patchogue : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Patchogue : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Patchogue : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Patchogue : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Plainview : Island Neurological Associates

A clinical study for patients with Multiple Sclerosis

Plainview : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Plainview : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Plainview : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Plainview : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Rochester : University of Rochester Medical Center

A clinical study for patients with Multiple Sclerosis

Rochester : University of Rochester

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Rochester : University of Rochester

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Rochester : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Rochester : University of Rochester

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Rochester : University of Rochester

Patients are needed to participate in a clinical research study of Lubiprostone and Placebo to evaluate Multiple Sclerosis or Constipation

Stony Brook : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Stony Brook : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Stony Brook : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Stony Brook : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Stony Brook : University at Stony Brook, The State University of New York

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Syracuse : SUNY Upstate Medical University

A clinical research study of Electrical impedance myography (EIM) for the treatment of Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Charcot-Marie-Tooth Disease or Multiple Sclerosis

Syracuse : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Syracuse : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Syracuse : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Syracuse : University at Upstate, The State University of New York

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

White Plains : Burke Rehabilitation Hospital

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

White Plains : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

White Plains : Burke Rehabilitation Hospital

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

North Carolina

Charlotte : PMG Research of Charlotte

Have you been diagnosed with a relapsing form of Multiple Sclerosis?

Charlotte : Duke University

The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort

Concord : Duke University

The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort

Kannapolis : Duke University

The MURDOCK Study Community Registry and Biorepository Primary Progressive Multiple Sclerosis Cohort

Winston-Salem : PMG Research of Winston-Salem

Do you have multiple sclerosis?

Winston-Salem : PMG Research of Winston-Salem

Does your Multiple Sclerosis keep you from walking comfortably?

Advance : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Asheville : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Chapel Hill : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Charlotte : The Neurological Institute, PA

A clinical study for patients with Multiple Sclerosis

Charlotte : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Charlotte : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Charlotte : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Charlotte : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Greensboro : Guilford Neurologic Associates, Inc.

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Greensboro : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Greensboro : Guilford Neurologic Associates, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Hickory : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Hickory : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Raleigh : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Raleigh : Receptos Study Site 143 Updated

A clinical trial to evaluate treatments using RPC1063 and Beta interferon for patients with Multiple Sclerosis

Raleigh : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Raleigh : Raleigh Neurology Associates PA

Patients are needed to participate in a clinical research study of Natalizumab to evaluate Relapsing Multiple Sclerosis

Winston-Salem : PMG Research of Winston-Salem

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Winston-Salem : Wake Forest University Health Sciences

A clinical research study of Electrical impedance myography (EIM) for the treatment of Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Charcot-Marie-Tooth Disease or Multiple Sclerosis

Winston-Salem : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Winston-Salem : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Winston-Salem : Teva Investigational Site 10347 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Winston-Salem : PMG Research of Winston-Salem

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Winston-Salem : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

North Dakota

Bismarck : St. Alexius Medical Center New

A research study for patients who have been diagnosed with multiple sclerosis

Bismarck : St. Alexius Medical Center

A research study for patients who have been diagnosed with multiple sclerosis

Grand Forks : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Ohio

Akron : Neurology & Associates, Inc.

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Akron : Receptos Study Site 107 Updated

A clinical trial to evaluate treatments using RPC1063 and Beta interferon for patients with Multiple Sclerosis

Akron : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Akron : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Akron : Neurology & Associates, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Akron : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Akron : Neurology and Neuroscience Associates, Inc.

Patients are needed to participate in a clinical research study of Natalizumab to evaluate Relapsing Multiple Sclerosis

Bellevue : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bellevue : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Bellevue : Teva Investigational Site 10309 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bellevue : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Canton : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Cincinnati : University of Cincinnati, Department of Neurology

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Cleveland : Rapid Medical Research Inc

A clinical research study of Baclofen dose 1, Baclofen dose 2 and Placebo for the treatment of Spasticity

Cleveland : Cleveland Clinic: Mellen Center for Multiple Sclerosis Updated

A clinical research study of Blood Draw and CSF collection by lumbar puncture (Optional) for the treatment of Secondary Progressive Multiple Sclerosis

Cleveland : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Cleveland : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Cleveland : Cleveland Clinic

A clinical trial to evaluate treatments for patients with Multiple Sclerosis (MS)

Cleveland : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Cleveland : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cleveland : Cleveland Clinic

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Columbus : The Ohio State University Medical Center, Cramblett Medical Clinic

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Columbus : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Columbus : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Columbus : Teva Investigational Site 10317 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Columbus : Teva Investigational Site 12976 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod and Placebo for the treatment of Primary Progressive Multiple Sclerosis

Columbus : The Ohio State University Medical Center, Cramblett Medical Clinic

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Columbus : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Columbus : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Columbus : Ohio State University

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Dayton : Neurology Specialists, Inc.

A clinical study for patients with Multiple Sclerosis

Dayton : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Dayton : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Dayton : Teva Investigational Site 10325 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Dayton : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Gahanna : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Toledo : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Toledo : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Toledo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Uniontown : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Uniontown : Teva Investigational Site 12970 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod and Placebo for the treatment of Primary Progressive Multiple Sclerosis

Oklahoma

Edmond : Retina Vitreous Center

A clinical trial to evaluate treatments for patients with Multiple Sclerosis (MS)

Oklahoma City : OMRF MS Center of Excellence

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Oklahoma City : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Oklahoma City : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Oklahoma City : Lynn Health Science Institute

A clinical trial to evaluate treatments for patients with Multiple Sclerosis (MS)

Oklahoma City : Radiology Associates

A clinical trial to evaluate treatments for patients with Multiple Sclerosis (MS)

Oklahoma City : OMRF MS Center of Excellence

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Oklahoma City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Oklahoma City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Tulsa : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Tulsa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Oregon

Corvallis : The Corvallis Clinic, P.C.

A clinical study for patients with Multiple Sclerosis

Medford : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Portland : Providence Multiple Sclerosis Center

A clinical study for patients with Multiple Sclerosis

Portland : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Portland : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Portland : Providence St. Vincent Medical Center

A clinical trial to evaluate treatments using ACTH and Placebo for patients with Multiple Sclerosis, Relapsing-Remitting

Portland : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Portland : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Portland : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Springfield : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Pennsylvania

Philadelphia : University of Pennsylvania New

Is Reuse of Intermittent Urethral Catheters Safe and Preferred? A Prospective, Observational Study Evaluating Reuse of Catheters and Switch to Single-use.

Abington : Abington Neurological Associates

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Abington : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Abington : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Abington : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Abington : Abington Neurological Associates

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Greensburg : Westmoreland Neurology

A clinical study for patients with Multiple Sclerosis

Greensburg : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Greensburg : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Hershey : Penn State University College of Medicine/MS Hershey Medical Center

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Hershey : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Hershey : Penn State University College of Medicine/MS Hershey Medical Center

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Monroeville : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Philadelphia : University of Pennsylvania Health System

A clinical study for patients with Multiple Sclerosis

Philadelphia : Temple University School of Medicine

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Philadelphia : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Philadelphia : Temple University School of Medicine

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Philadelphia : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Philadelphia : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Pittsburgh : Research Protocol Management Solutions

A clinical study for patients with Multiple Sclerosis

Pittsburgh : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Pittsburgh : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Pittsburgh : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Pittsburgh : University of Pittsburgh

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Tarentum : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Rhode Island

Providence : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

South Carolina

Greenville : Duke University

The MURDOCK Study Community Registry and Biorepository Multiple Sclerosis Cohort

Columbia : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Greenville : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Indian Land : Metrolina Neurological Associates, PA Neurology

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Indian Land : Metrolina Neurological Associates, PA Neurology

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Spartanburg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Spartanburg : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Tennessee

Cordova : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cordova : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Franklin : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Franklin : Teva Investigational Site 10324 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Knoxville : Research Site

A clinical research study of Rebif® Rebidose® and Rebiject II® for the treatment of Multiple Sclerosis, Relapsing-Remitting

Knoxville : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Knoxville : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Knoxville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Knoxville : Hope Neurology

Patients are needed to participate in a clinical research study of Natalizumab to evaluate Relapsing Multiple Sclerosis

Nashville : Teva Investigational Site 10318 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Nashville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Nashville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Nashville : Vanderbilt University

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Texas

Dallas : Baylor Research Institute

Study of NUEDEXTA in the Treatment of Pseudobulbar Affect (PBA)

San Antonio : Innovative Clinical Trials

Multiple Sclerosis with Spasticity

San Antonio : Innovative Clinical Trials

Multiple Sclerosis with Spasticity

Austin : Future Search Trials of Neurology, LP

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Austin : Future Search Trials of Neurology, LP

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Colleyville : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Dallas : University of Texas Southwestern

A clinical study for patients with Multiple Sclerosis

Dallas : Baylor Research Institute

A clinical study for patients with Multiple Sclerosis

Dallas : Baylor Research Institute / MS Treatment Center of Dallas

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Dallas : UT Southwestern Medical Center

A clinical trial to evaluate treatments using ACTHAR Gel (ACTH) and IV steroids with oral taper for patients with Multiple Sclerosis

Dallas : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Dallas : Baylor Research Institute / MS Treatment Center of Dallas

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Dallas : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Dallas : University of Texas Southwestern Medical Center

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Houston : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Kingwood : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Lubbock : Receptos Study Site 138 Updated

A clinical trial to evaluate treatments using RPC1063 and Beta interferon for patients with Multiple Sclerosis

Lubbock : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Round Rock : Central Texas Neurology Consultants, P.A.

A clinical study for patients with Multiple Sclerosis

Round Rock : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Round Rock : Research Site

A clinical trial to evaluate treatments using natalizumab and fingolimod for patients with Relapsing-Remitting Multiple Sclerosis

Round Rock : Investigational Site Number 840003

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Round Rock : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Round Rock : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Round Rock : Central Texas Neurology Consultants

Patients are needed to participate in a clinical research study of Natalizumab to evaluate Relapsing Multiple Sclerosis

San Antonio : Innovative Clinical Trials, Bexar Diagnostic Medicine Assoc.

A clinical study for patients with Multiple Sclerosis

San Antonio : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

San Antonio : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

San Antonio : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Sherman : Texoma Neurology Associates

A clinical study for patients with Multiple Sclerosis

Sherman : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Utah

Salt Lake City : Rocky Mountain MS Clinic

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Secondary Progressive Multiple Sclerosis or Clinically Isolated Syndrome

Salt Lake City : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Salt Lake City : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Salt Lake City : Investigational Site Number 840002

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Salt Lake City : Rocky Mountain MS Research Group

A Phase 4 clinical study for patients with Relapsing Remitting Multiple Sclerosis

Salt Lake City : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Salt Lake City : University of Utah

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Vermont

Burlington : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Burlington : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Burlington : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Virginia

Alexandria : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Alexandria : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Charlottesville : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Charlottesville : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Charlottesville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Charlottesville : University of Virginia Charlottesville

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Henrico : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Newport News : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Newport News : Teva Investigational Site 10330 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Norfolk : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Norfolk : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Norfolk : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Reston : Research Site

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis or Exposure During Pregnancy

Richmond : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Roanoke : Research site

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Roanoke : Teva Investigational Site 10311 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Washington

Issaquah : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Kirkland : MS Center at Evergreen Health

A clinical research study for the treatment of Multiple Sclerosis

Kirkland : EvergreenHealth MS Center

Patients are needed to participate in a clinical research study evaluating Mirabegron and Placebo for the treatment of Multiple Sclerosis

Seattle : Pacific Medical Centers

A clinical study for patients with Multiple Sclerosis

Seattle : Swedish Neuroscience Institute

A clinical study for patients with Multiple Sclerosis

Seattle : Swedish Neuroscience Institute Updated

A clinical research study of Blood Draw and CSF collection by lumbar puncture (Optional) for the treatment of Secondary Progressive Multiple Sclerosis

Seattle : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Seattle : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Seattle : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Seattle : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Seattle : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Seattle : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Seattle : Teva Investigational Site 10335 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Seattle : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Seattle : Swedish Medical Center - Seattle

Patients are needed to participate in a clinical research study of ibudilast and Placebo to evaluate Multiple Sclerosis, Primary Progressive or Multiple Sclerosis, Secondary Progressive

Tacoma : MultiCare Research Institute

A clinical study for patients with Multiple Sclerosis

Tacoma : Multicare Institute for Research and Innovations

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Tacoma : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Tacoma : Research Site

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Tacoma : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Tacoma : Multicare Institute for Research and Innovations

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Tacoma : Multicare Health System Institute for Research and Innovation

Patients are needed to participate in a clinical research study of Natalizumab to evaluate Relapsing Multiple Sclerosis

West Virginia

Huntington : Marshall University

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Huntington : Marshall University

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Wisconsin

Green Bay : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Madison : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Milwaukee : Wheaton Franciscan Heatlhcare-St. Francis Center of Neurological Disorders Outpatient Center

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Milwaukee : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Milwaukee : Wheaton Franciscan Heatlhcare-St. Francis Center of Neurological Disorders Outpatient Center

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Neenah : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Neenah : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate for the treatment of Relapsing Forms of Multiple Sclerosis

Waukesha : Cardiovascular & Neurosciences Research Institute, ProHealth Care, Inc

A clinical research study of Baclofen ER Capsules and Placebo GRS for the treatment of Spasticity

Waukesha : Cardiovascular & Neurosciences Research Institute, ProHealth Care, Inc.

Patients are needed to participate in a clinical research study of Baclofen to evaluate Spasticity

Albania

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Algeria

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Argentina

Buenos Aires : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Buenos Aires : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Buenos aires : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Caba : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Capital Federal : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cordoba : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Australia

Adelaide : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Adelaide : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Auchenflower : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Bedford Park : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Box Hill : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Box Hill : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Box Hill : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Box Hill : Research Site

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis or Exposure During Pregnancy

Brisbane : The Wesley-St. Andrew's Research Institute

A clinical research study of MIS416 and Saline for the treatment of Secondary Progressive Multiple Sclerosis

Brisbane : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Brisbane Queensland : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Camperdown : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Camperdown : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Clayton : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Concord : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

East Gosford : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Fitzroy : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Fitzroy : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Fitzroy : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Geelong VIC : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Greelong : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Heidelberg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Heidelberg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Hobart : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Kanwal : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Kogarah : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Kogarah : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Liverpool : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Liverpool : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Liverpool : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Melbourne : Nucleus Network - Centre for Clinical Studies

A clinical research study of MIS416 and Saline for the treatment of Secondary Progressive Multiple Sclerosis

Melbourne : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Melbourne : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Nedlands : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Nedlands : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

New Lambton Heights : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

New Lambton Heights : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Parkville : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Parkville : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Parkville : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Parkville : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Parkville : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Parkville/Melbourne : Investigational Site Number 036001

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Perth : Western Australian Neuroscience Research Institute

A clinical research study of MIS416 and Saline for the treatment of Secondary Progressive Multiple Sclerosis

Perth : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Randwick : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Southport : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Sydney : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Sydney : Novartis Investigative Site

A clinical trial to evaluate treatments using Fingolimod (FTY720) for patients with Relapsing Remitting Multiple Sclerosis

Austria

Innsbruck : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Innsbruck : Teva Investigational Site 33013 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Klagenfurt : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Klagenfurt : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Linz : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Linz : Teva Investigational Site 33014 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Many locations :

A clinical trial to evaluate treatments using Betaferon, (BAY 86-5046) and BETACONNECT for patients with Multiple Sclerosis, Relapsing Remitting

Salzburg : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

St. Polten : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Vienna : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Vienna : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Vienna : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Vienna : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Villach : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Wien : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Wien : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Wien : Teva Investigational Site 33016 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Wien : Teva Investigational Site 33015 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Belarus

Grodno : Teva Investigational Site 68013 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Minsk : Teva Investigational Site 68009 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Minsk : Teva Investigational Site 68012 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Minsk : Teva Investigational Site 68008 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Vitebsk : Teva Investigational Site 68011 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Belgium

Antwerpen : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Brabant Wallon : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Brugge : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Brugge : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Brussels : Investigational Site Number 056001

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Brussels : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Bruxelles : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Bruxelles : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Bruxelles : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Charleroi : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Edegem : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Gent : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Gent : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Hainaut : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

La Louvière : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Leuven : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Leuven : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Leuven : Investigational Site Number 056001

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Liege : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Liège : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Limburg : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Luxembourg : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Many locations :

A clinical trial to evaluate treatments using Betaferon, (BAY 86-5046) and BETACONNECT for patients with Multiple Sclerosis, Relapsing Remitting

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Melsbroek : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Melsbroek : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Oost-Vlaanderen : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Overpelt : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tinlot (Fraiture) : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

West-Vlaanderen : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis

Bosnia and Herzegovina

Mostar : Teva Investigational Site 69008 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sarajevo : Teva Investigational Site 69006 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tuzla : Teva Investigational Site 69009 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Brazil

Belo Horizonte : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Goiânia : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Joinville : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Porto Alegre : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Porto Alegre : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

São Paulo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Bulgaria

Pleven : Teva Investigational Site 59040 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Pleven : Teva Investigational Site 59039 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Ruse : Teva Investigational Site 59061 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Shumen : Teva Investigational Site 59055 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sofia : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sofia : Teva Investigational Site 59043 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59050 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59052 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59059 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59063 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59045 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59041 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59058 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59057 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59054 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59042 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59038 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59048 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sofia : Teva Investigational Site 59044 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Varna : Teva Investigational Site 59046 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Veliko Tarnovo : Teva Investigational Site 59051 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Veliko Tarnovo : Teva Investigational Site 59053 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Vidin : Teva Investigational Site 59060 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Canada

Bracebridge : South Muskoka Medical Clinic

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Burnaby : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Burnaby : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Calgary : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Calgary : Multiple Sclerosis Clinic

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Calgary : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Calgary : Investigational Site Number 124001

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Cambridge : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Chicoutimi : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Edmonton : University of Alberta

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Edmonton : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Gatineau : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Gatineau : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Gatineau : Clinique Neuro-Outaouais

Patients are needed to participate in a clinical research study of extended release fampridine and Placebo to evaluate Multiple Sclerosis

Greenfield Park : Investigational Site Number 124001

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Halifax : Biogen Idec Investigative Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Halifax : Dalhousie MS Research Unit

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Halifax : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Halifax : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Hamilton : St. Joseph Healthcare, Subject Recruitment Site

A Phase 1 clinical study for patients with Evaluate the Safety of GEH120714 (18F) Injection in Healthy Volunteers (HV) and Participants With rrMS.

London : Biogen Idec Investigative Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

London : London Health Sciences Centre

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

London : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Milton : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Montreal : Biogen Idec Investigative Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Montreal : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Montreal : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Montreal : McGill University - MNI

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Montreal : Montreal Neurological Institute

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis-Relapsing-Remitting

Montreal : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Montreal : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Montreal : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Montreal : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Ottawa : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Ottawa : The Ottawa Hospital

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Ottawa : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Ottawa : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Regina : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Saint John : Private Community Clinic

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Saint John : Saint John Regional Hospital

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Saskatoon : Teva Investigational Site 11016 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

St. John's : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Sydney : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Thunder Bay : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Toronto : Sunnybrook Health Sciences Centre

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Toronto : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Toronto : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Toronto : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Toronto : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Toronto : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Vancouver : Vancouver Coastal Health: University of British Columbia Hospital

A clinical study for patients with Multiple Sclerosis

Vancouver : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Victoria : Biogen Idec Investigative Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Chile

Santiago : Multiple Sclerosis Centre, Pontificia Universidad Catolica de Chile

A clinical trial seeking patients for a Primary Progressive Multiple Sclerosis or Multiple Sclerosis (MS), Secondary Progressive treatment research study

Santiago : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Santiago : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

China

Beijing : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Beijing : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Beijing : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Changchun : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Nanjing : Nanjing University Medical College Affiliated Drum Tower Hospital

A clinical research study of human umbilical cord mesenchymal stem cells for the treatment of Progressive Multiple Sclerosis or Neuromyelitis Optica.

Shanghai : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Shanghai : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Taiyuan : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Xi'an : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Croatia

Osijek : Teva Investigational Site 60010 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Zagreb : Teva Investigational Site 60009 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Czech Republic

Brno : Fakultni nemocnice u sv. Anny v Brne

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Brno : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Brno : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Brno : Teva Investigational Site 54042 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Brno : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Brno : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Ceské Budesovice : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Havirov : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Havirov : Neurospol, s.r.o.

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Havirov : Teva Investigational Site 54043 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Hradec Kralove : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Hradec Kralove : Fakultni nemocnice Hradec Kralove

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Hradec Kralove : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Hradec Kralové : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Hradec Kralove 3 : Teva Investigational Site 54047 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Jihlava : Nemocnice Jihlava

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

JIhlava : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Jihlava : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Jihlava : Teva Investigational Site 54046 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Jihlava : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Olomouc : Teva Investigational Site 54044 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Olomouc : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Ostrava : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Ostrava-Poruba : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Pardubice : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Pardubice : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Plzen : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Plzen : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Prague : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Prague 10 : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Prague 4 : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Praha 2 : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Praha 2 : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Praha 2 : Investigational Site Number 4801

Patients are needed to participate in a clinical research study evaluating alemtuzumab GZ402673 for the treatment of Relapsing Remitting Multiple Sclerosis

Praha 5 : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Teplice : Krajska zdravotni, a.s. - Nemocnice Teplice, o.z.

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Teplice : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Teplice : Teva Investigational Site 54048 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Teplice : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Zlín : Research site

Patients are needed to participate in a clinical research study evaluating Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis

Denmark

Aarhus : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Aarhus : Sport Science, Department of Public Health, Aarhus University

Patients are needed to participate in a clinical research study evaluating Aerobic exercise for the treatment of Multiple Sclerosis

Aarhus C : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Århus C : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Esbjerg : Research Site

A clinical trial to evaluate treatments for patients with Exercise

København Ø : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Odense : Odense University Hospital

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Odense : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Odesse : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Vejle : Research Site

A clinical trial to evaluate treatments for patients with Exercise

Egypt

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Estonia

Paernu : Teva Investigational Site 55005 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tallinn : Receptos Study Site 473 Updated

A clinical trial to evaluate treatments using RPC1063 and Beta interferon for patients with Multiple Sclerosis

Tallinn : Receptos Study Site 471 Updated

A clinical trial to evaluate treatments using RPC1063 and Beta interferon for patients with Multiple Sclerosis

Tallinn : Teva Investigational Site 55006 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tallinn : Teva Investigational Site 55008 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tallinn : Investigational Site Number 233001

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Tartu : Receptos Study Site 472 Updated

A clinical trial to evaluate treatments using RPC1063 and Beta interferon for patients with Multiple Sclerosis

Tartu : Teva Investigational Site 55007 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Finland

Helsinki : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Turku : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

France

Amiens Cedex 1 : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Besancon cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Bordeaux : Service de Neurologie - Pôle des Neurosciences Cliniques, CHU de Bordeaux.

A clinical study for patients with Multiple Sclerosis or Cognitive Rehabilitation

Bordeaux : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Bordeaux : Service de Neurologie - Tripode - Hôpital Pellegrin

Patients are needed to participate in a clinical research study of Blood samples to evaluate Multiple Sclerosis

Bordeaux Cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Bordeaux Cedex : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Bordeaux Cedex : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Bron Cedex : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

CAEN Cedex : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Clermont-Ferrand Cedex 1 : Teva Investigational Site 35075 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Dijon : Investigational Site Number 250009

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Dijon : Teva Investigational Site 35077 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Dijon Cedex : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

La Roche sur Yon : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Le Chesnay Cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Le Kremlin Bicetre : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Le Kremlin Bicetre : Investigational Site Number 250001

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Lille : Teva Investigational Site 35073 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Lille Cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Lille Cedex : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Lille Cedex : Investigational Site Number 250005

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Limoges cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Lyon Bron : Investigational Site Number 250001

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Lyon Cedex 03 : Investigational Site Number 250002

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Lyon cedex 04 : Teva Investigational Site 35076 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Marseille : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Marseille : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Marseille : Investigational Site Number 250004

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Marseille cedex 05 : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Marseille cedex 05 : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Montpellier : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Montpellier : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Nancy : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Nancy : Investigational Site Number 250006

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Nancy : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Nantes : Investigational Site Number 250010

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Nantes cedex 1 : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Nantes Cedex 1 : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Nimes : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Nimes : Investigational Site Number 250007

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Nimes : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Nîmes : Teva Investigational Site 35079 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Paris Cedex 13 : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Paris Cedex 13 : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

PARIS Cedex 20 : Investigational Site Number 250008

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Poitiers cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Reims : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Rennes : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Rennes Cedex : Investigational Site Number 250003

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Rennes cedex 09 : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Rennes cedex 09 : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

RENNES Cedex 9 : Investigational Site Number 250004

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Rouen Cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

St Herblain : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Strasbourg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Strasbourg : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Strasbourg Cedex : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Strasbourg Cedex 2 : Investigational Site Number 250003

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Toulouse : Investigational Site Number 250002

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Toulouse cedex 1 : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Georgia

Tbilisi : Teva Investigational Site 81016 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81018 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81014 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81017 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81019 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tbilisi : Teva Investigational Site 81015 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Germany

Aachen : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Aachen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aachen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aalen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aalen-Wasseralfingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Abensberg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Achim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aichach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Altenburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Altenholz-Stift : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Alzenau : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Alzenau : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Andernach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Asbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Aschaffenburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Augsburg : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Augsburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Homburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Honnef : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Bad Honnef : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Krozingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Mergentheim : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Bad Mergentheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Saarow : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bad Wildbad : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bamberg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Bamberg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bamburg : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Bayreuth : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Bayreuth : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bergisch Gladbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Berlin : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Berlin : Investigational Site Number 276001

A clinical trial to evaluate treatments for patients with Progressive Multiple Sclerosis

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Berlin : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Berlin : Teva Investigational Site 32186 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Berlin : Teva Investigational Site 32176 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Berlin : Teva Investigational Site 32198 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Berlin : Investigational Site Number 276001

Patients are needed to participate in a clinical research study to evaluate Progressive Multiple Sclerosis

Bielefeld : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bielefeld : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Böblingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Bochum : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Bochum : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bochum : Teva Investigational Site 32177 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bochum : Research Site

Patients are needed to participate in a clinical research study for the treatment of Multiple Sclerosis or Pregnancy

Bochum : Novartis Investigative Site

Patients are needed to participate in a clinical research study of Fingolimod to evaluate Multiple Sclerosis

Bogen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bonn : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Bonn : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Bonn : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Bonn : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Borna : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bottrop : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Braunschweig : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Bremen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Buchholz : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Buchholz : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Buchholz in der Nordheide : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Butzbach : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Butzbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Celle : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Chemnitz : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Chemnitz : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Darmstadt : Please contact the Merck KGaA Communication Center

A Phase 2 clinical study for patients with Multiple Sclerosis

Darmstadt : Please contact the Merck KGaA Communication Center

Patients are needed to participate in a clinical research study of Rebif® to evaluate Multiple Sclerosis, Relapsing-Remitting

Delbrueck : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dillingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dillingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dortmund : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dortmund : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dresden : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Dresden : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Dresden : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Dresden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dresden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Dresden : Teva Investigational Site 32193 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Duesseldorf : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Duesseldorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Duesseldorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Düren : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Düsseldorf : Heinrich Heine Universität Düsseldorf

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis

Düsseldorf : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Düsseldorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Düsseldorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Eberswalde : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Eisenach : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Eisenach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Eltville : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Eltville : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Emden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Emmendingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Erbach : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Erbach : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Erbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Erfurt : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Erfurt : Teva Investigational Site 32189 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Erlangen : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Erlangen : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Erlangen : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Erlangen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Eschwege : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Essen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Flensburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Frankfurt : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Frankfurt : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Frankfurt am Main : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Frankfurt am Main : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Freiburg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Freiburg : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Freiburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Freiburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Friedrichshafen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Fulda : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Fulda : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Geldern : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gelnhausen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gelsenkirchen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gießen : Teva Investigational Site 32203 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gilching : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gladenbach : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Gladenbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Goettingen : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Goettingen : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Goettingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Goettingen : Teva Investigational Site 32202 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gorlitz : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Göttingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Greifswald : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Grevenbroich : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Griesheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Guetersloh : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Gummersbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Haar : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hagen : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Hagen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Halle : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Halle (Saale) : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Halle (Saale) : Teva Investigational Site 32196 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Halle/S. : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Hamburg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hamburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hannover : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Hannover : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hannover : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hannover : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Heidelberg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Heidelberg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Heidelberg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Heidenheim : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Heidenheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Herdecke : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Herford : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Herford : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hildesheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Homburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Hoppegarten : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ibbenbueren : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ibbenbüren : Teva Investigational Site 32175 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Idar-Oberstein : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Itzehoe : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Jena : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Jena : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Jena : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Jena : Teva Investigational Site 32201 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Juelich : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kaiserslautern : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kaltenkirchen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kamen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kandel : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Karlstadt : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kassel : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Kassel : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Kassel : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Kiel : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Klingenmünster : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Koeln : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Koln : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Koln : Teva Investigational Site 32183 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Köln : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Köln : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Königsbrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Korbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Krefeld : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Krefeld : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Krefeld : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Landshut : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Landshut : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lappersdorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Leipzig : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Leipzig : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Leipzig : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Leipzig : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Leipzig : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Leipzig : Teva Investigational Site 32190 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Leverkusen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lohr am Main : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lübeck : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ludwigshafen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ludwigshafen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lüneburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Lutherstadt Eisleben : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Magdeburg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Magdeburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Magdeburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Magdeburg : Teva Investigational Site 32185 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Mannheim : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Mannheim : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Mannheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mannheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Many Locations : Updated

A clinical study for patients with Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaferon, BAY 86-5046) to evaluate Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Marburg : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Marburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Meisenheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Minden : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Minden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Minden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mittweida : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mönchengladbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mönchengladbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Mosbach : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Muenchen : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Muenchen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Muenster : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Muenster : Universitaetsklinikum Muenster, Department of Neurology

Patients are needed to participate in a clinical research study evaluating Fingolimod and Natalizumab for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Mülheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Munchen : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

München : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

München : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

München : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

München : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Münster : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Nagold : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Neuberg : Research Site

A clinical research study for the treatment of Multiple Sclerosis

Neuburg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Neuburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Neuruppin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Neusäß : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Neu-Ulm : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Nordhausen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Nurnberg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Nürnberg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Öhringen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Oldenburg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Oldenburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Oldenburg i. Holstein : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Osnabruck : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Osnabrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Osnabrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Osnabrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Osnabrueck : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ostfildern : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Pforzheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Potsdam : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Potsdam : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Prien : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Quakenbrück : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Querfurt : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ravensburg : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Ravensburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Recklinghausen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Regensburg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Regensburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Remscheid : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Remscheid : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Rosrath : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Rostock : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Rostock : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Rostock : Teva Investigational Site 32191 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Rüdersdorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Saarbrücken : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Schwalmstadt-Treysa : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Schwerin : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Siegen : Research Site

A clinical trial seeking patients for a research study for the treatment of Relapsing-Remitting Multiple Sclerosis

Siegen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Singen : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Singen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Sinsheim : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Solingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

St. Ingbert : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stade : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stadtroda : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stralsund : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stuttgart : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Stuttgart : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stuttgart : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stuttgart : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Stuttgart : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Telgte : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Teupitz : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Troisdorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Tübingen : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tübingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ulm : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Ulm : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Ulm : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Ulm : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ulm : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Ulm : Teva Investigational Site 32173 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Unterhachin : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Unterhaching : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wasserburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wendlingen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wermsdorf : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS)

Wermsdorf : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Wermsdorf : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Westerstede : Teva Investigational Site 32188 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Westerstede/Oldenburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wiesbaden : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Wiesbaden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wiesbaden : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wolfratshausen : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Wolfratshausen : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Wuppertal : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Wuppertal : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Würzburg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Würzburg : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Zwickau : Novartis Investigative Site

A Phase 4 clinical study for patients with Multiple Sclerosis

Greece

Athens : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Athens : Teva Investigational Site 63027 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Athens : Teva Investigational Site 63024 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Heraklion Crete : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Larissa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Thessaloniki : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Thessaloniki : Teva Investigational Site 63025 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Thessaloniki : Teva Investigational Site 63028 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Thessaloniki : Investigational Site Number 300001

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Hungary

Budapest : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Budapest : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Budapest : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Budapest : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Budapest : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Budapest : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Budapest : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Debrecen : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Debrecen : Teva Investigational Site 51043 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gyor : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Kaposvar : Teva Investigational Site 51044 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Miskolc : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Szeged : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Veszprem : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Veszprem : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Ireland

Cork : Biogen Idec Investigative Site

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis, Relapsing-Remitting or Relapsing Remitting Multiple Sclerosis

Dublin : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate, Acetylsalicylic acid and ASA-Placebo for the treatment of Relapsing-Remitting Multiple Sclerosis

Dublin : Biogen Idec Investigative Site

Patients are needed to participate in a clinical research study to evaluate Multiple Sclerosis, Relapsing-Remitting or Relapsing Remitting Multiple Sclerosis

Israel

Ashkelon : Barzilai Medical Center

A clinical research study of GA Depot for the treatment of Multiple Sclerosis (RRMS)

Haifa : Carmel Medical Center

A clinical research study of GA Depot for the treatment of Multiple Sclerosis (RRMS)

Haifa : Teva Investigational Site 80023 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Haifa : Teva Investigational Site 80024 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Jerusalem : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Jerusalem : Investigational Site Number 376001

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Ramat Gan : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ramat Gan : Teva Investigational Site 80020 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tel Aviv : TASMC

A clinical research study of GA Depot for the treatment of Multiple Sclerosis (RRMS)

Tel Aviv : RedHill MS Clinical Trial Site 002

Patients are needed to participate in a clinical research study evaluating RHB-104 for the treatment of Relapsing Remitting Multiple Sclerosis

Tel Hashomer : Sheba MC

A clinical research study of GA Depot for the treatment of Multiple Sclerosis (RRMS)

Tel Hashomer : Investigational Site Number 376003

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Tel-Aviv : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tel-Aviv : Teva Investigational Site 80021 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tel-Aviv : Investigational Site Number 376002

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Tzrifin : Investigational Site Number 376004

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Zefat (Safed) : RedHill MS Clinical Trials Site 001

Patients are needed to participate in a clinical research study evaluating RHB-104 for the treatment of Relapsing Remitting Multiple Sclerosis

Italy

Bari : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Bari : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Bologna : Teva Investigational Site 30037 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Castelfiorentino : Teva Investigational Site 30031 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Catania : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Catania : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Cefalù : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Cefalù : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Cefalù : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Cefalù (Palermo) : Teva Investigational Site 30030 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Chieti : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Chieti : Teva Investigational Site 30032 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Como : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Firenze : Teva Investigational Site 30024 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gallarate : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Gallarate : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Gallarate : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Gallarate : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Gallarate (Varese) : Teva Investigational Site 30029 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Genova : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Genova : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Genova : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Many locations :

A clinical trial to evaluate treatments using Betaferon, (BAY 86-5046) and BETACONNECT for patients with Multiple Sclerosis, Relapsing Remitting

Milano : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Milano : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Milano : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Milano : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Milano : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Milano : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Milano : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Milano : Teva Investigational Site 30039 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Milano : Teva Investigational Site 30023 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Montichiari : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Montichiari : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Napoli : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Napoli : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Napoli : Teva Investigational Site 30034 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Orbassano : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Padova : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Roma : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Roma : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Roma : Teva Investigational Site 30026 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Roma : Teva Investigational Site 30028 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Roma : Teva Investigational Site 30035 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Roma : Teva Investigational Site 30025 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Verona : Teva Investigational Site 30040 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Japan

Aomori : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Asahikawa-shi : NHO Asahikawa Medical Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Bunkyo-ku : Juntendo University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Chiba : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Chiba-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Chiba-shi : Chiba University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Fuchu : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Fukuoka-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Fukuoka-shi : Kyushu University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Fukuoka-shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Kahoku-gun : Kanazawa Medical University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kawagoe-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Kawagoe-shi : Saitama Medical Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kawagoe-shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Kobe-shi : Kobe University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kodaira-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Kodaira-shi : National Center Hospital, NCNP

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kodaira-shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Kyoto-shi : NHO Utano Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kyoto-shi : Kyoto University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Morioka : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Morioka-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Morioka-shi : Iwate Medical University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Niigata : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Niigata-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Niigata-shi : Niigata University Medical & Dental Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Osaka : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Osaka-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Osakasayama-shi : Kinki University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Osaka-shi : Irino Clinic, Inc.

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Ota-ku : Tokyotohokeniryokosya Ebara Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Ota-ku : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sapporo : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Sapporo-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Sapporo-shi : CEReS Sapporo Neurology Clinic

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Sapporo-shi : NHO Hokkaido Medical Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Sapporo-Shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Sendai : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Sendai-shi : Tohoku University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Shinjuku-ku : Department of Neurosurgery, Tokyo Women's Medical University

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Shinjuku-ku : Keio University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Shinjuku-ku : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Shinjuku-ku : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Suita-shi : Osaka University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Tokorozawa-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tokorozawa-shi : National Defense Medical College Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Tokyo : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Toon-shi : Ehime University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Toon-shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Tsukuba-city : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tsukuba-shi : Tsukuba University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Ube-shi : Yamaguchi University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Yachiyo-shi : Tokyo Womens Medical University Yachiyo Medical Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Yachiyo-shi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Yamaguchi : Research Site

Patients are needed to participate in a clinical research study evaluating Placebo and fampridine (BIIB041)

Yokohama-shi : Yokohama City University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Kazakhstan

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Korea, Republic of

Daegu : Yeungnam University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Goyang, GYEONGGI-DO : Teva Investigational Site 87001 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gyeonggi-do : National Cancer Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Seoul : Samsung Medical Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Seoul : Seoul National University Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Seoul : Asan Medical Center

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Seoul : Korea University Anam Hospital

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Seoul : Teva Investigational Site 87002 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Latvia

Riga : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Riga : Teva Investigational Site 56006 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Riga : Teva Investigational Site 56005 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Lebanon

Beirut : Investigational Site Number 422001

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Lithuania

Kaunas : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Macedonia, The Former Yugoslav Republic of

Skopje : Teva Investigational Site 65012 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Skopje : Teva Investigational Site 65011 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Skopje : Teva Investigational Site 65010 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Mexico

Aguascalientes : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Chihuahua : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Chihuahua : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Mexico : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

México : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Mexico City : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Monterrey : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Monterrey : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

San Luis Potosi : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Moldova, Republic of

Chisinau : Teva Investigational Site 70005 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Chisinau : Teva Investigational Site 70008 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Chisinau : Teva Investigational Site 70006 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Montenegro

Podgorica : Teva Investigational Site 66002 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Netherlands

Amsterdam : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Amsterdam : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Amsterdam : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Breda : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Breda : Investigational Site Number 528001

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Breda : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Breda : Amphia Ziekenhuis

Patients are needed to participate in a clinical research study evaluating glatiramer acetate for the treatment of Multiple Sclerosis

Eindhoven : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Eindhoven : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Gouda : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Hoorn : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Nieuwegein : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Rotterdam : Investigational Site Number 528002

A clinical trial to evaluate treatments for patients with Relapsing-remitting Multiple Sclerosis

Rotterdam : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Sittard : Maasland Ziekenhuis

Patients are needed to participate in a clinical research study evaluating glatiramer acetate for the treatment of Multiple Sclerosis

Sittard-Geleen : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Sittard-Geleen : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Tilburg : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Tilburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Norway

Bodo : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Molde : Molde Hospital

A clinical research study for the treatment of Multiple Sclerosis

Namsos : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Stavanger : Stavanger University Hospital

A clinical research study for the treatment of Multiple Sclerosis

Peru

Jesus Maria : Novartis Investigative Site

A clinical trial to evaluate treatments using FTY720 for patients with Relapsing Forms of Multiple Sclerosis

Poland

Bialystok : Teva Investigational Site 53071 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bydgoszcz : Novartis Investigative Site

A clinical research study of VAY736 and Placebo for the treatment of Relapse Remitting Multiple Sclerosis

Bydgoszcz : Teva Investigational Site 53085 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Czestochowa : Teva Investigational Site 53084 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gdansk : Copernicus Podmiot Leczniczy Sp. z o.o.

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Gdansk : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Gdansk : Teva Investigational Site 53083 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gdansk : Teva Investigational Site 53069 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Gdansk : Teva Investigational Site 53067 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Grodzisk Mazowiecki : Teva Investigational Site 53078 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Katowice : Nzoz Novo-Med

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Katowice : M.A. - LEK A.M.Maciejowscy SC.

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Katowice : Novartis Investigative Site

A clinical research study of VAY736 and Placebo for the treatment of Relapse Remitting Multiple Sclerosis

Katowice : Teva Investigational Site 53073 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Katowice : Teva Investigational Site 53080 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Katowice : Teva Investigational Site 53074 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Katowice : Teva Investigational Site 53070 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Konskie : Novartis Investigative Site

A clinical research study of VAY736 and Placebo for the treatment of Relapse Remitting Multiple Sclerosis

Konskie : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Konskie : Teva Investigational Site 53064 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Konstancin-Jeziorna : Teva Investigational Site 53065 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Koscierzyna : Teva Investigational Site 53072 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Krakow : MCD Medical

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Lodz : Novartis Investigative Site

A clinical research study of VAY736 and Placebo for the treatment of Relapse Remitting Multiple Sclerosis

Lodz : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Lodz : Investigational Site Number 616001

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Lodz : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Lublin : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Lublin : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Many Locations :

A clinical trial to evaluate treatments using Interferon beta-1b (Betaseron, BAY86-5046) for patients with Multiple Sclerosis

Olsztyn : Teva Investigational Site 53079 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Plewiska : Neurologiczny NZOZ Centrum Leczenia SM

A clinical research study of Placebo and BG00012 for the treatment of Multiple Sclerosis, Relapsing-Remitting or Multiple Sclerosis

Poznan : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Poznan : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Poznan / Plewiska : Teva Investigational Site 53068 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Szczecin : Teva Investigational Site 53076 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Warszawa : Novartis Investigative Site

A clinical research study of VAY736 and Placebo for the treatment of Relapse Remitting Multiple Sclerosis

Warszawa : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Warszawa : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Primary Progressive Multiple Sclerosis

Portugal

Amadora : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Amadora : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Braga : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Guimarães : Research Site

A clinical research study of dimethyl fumarate (DMF) for the treatment of Relapsing-Remitting Multiple Sclerosis or Multiple Sclerosis

Lisboa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Porto : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Puerto Rico

Guaynabo : Caribbean Center for Clinical Research, Inc.

A clinical study for patients with Multiple Sclerosis

Guaynabo : Research Site

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Guaynabo : Novartis Investigative Site

Patients are needed to participate in a clinical research study of fingolimod and copaxone to evaluate Relapsing-remitting Multiple Sclerosis (RRMS)

Romania

Balotesti : Teva Investigational Site 52045 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bucharest : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Bucharest : Teva Investigational Site 52041 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bucuresti : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Bucuresti : Teva Investigational Site 52050 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bucuresti : Teva Investigational Site 52037 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Bucuresti : Teva Investigational Site 52034 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Cluj-Napoca : Teva Investigational Site 52040 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Cluj-Napoca : Teva Investigational Site 52036 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Constanta : Teva Investigational Site 52044 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Constanta : Teva Investigational Site 52038 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Dolj : Teva Investigational Site 52048 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Hunedoara : Teva Investigational Site 52049 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Iasi : Teva Investigational Site 52042 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Oradea : Teva Investigational Site 52039 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Piatra-Neamt : Teva Investigational Site 52047 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sibiu : Teva Investigational Site 52046 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tg. Mures : Teva Investigational Site 52035 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Timisoara : Teva Investigational Site 52043 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Russian Federation

Barnaul : Teva Investigational Site 50130 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Chelyabinsk : Teva Investigational Site 50129 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Kazan : Investigational Site Number 643010

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Kazan : Investigational Site Number 6009

Patients are needed to participate in a clinical research study evaluating alemtuzumab GZ402673 for the treatment of Relapsing Remitting Multiple Sclerosis

Moscow : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

Moscow : Investigational Site Number 6005

Patients are needed to participate in a clinical research study evaluating alemtuzumab GZ402673 for the treatment of Relapsing Remitting Multiple Sclerosis

Moscow : Teva Investigational Site 50133 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Moscow : Teva Investigational Site 50146 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Moscow : Teva Investigational Site 50147 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Moscow : Teva Investigational Site 50124 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Nizhniy Novgorod : Investigational Site Number 643005

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Nizhny Novgorod : Teva Investigational Site 50141 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Nizhny Novgorod : Teva Investigational Site 50131 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Nizhny Novgorod : Teva Investigational Site 50128 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Novosibirsk : Investigational Site Number 643008

A Phase 2 clinical study for patients with Relapsing-remitting Multiple Sclerosis

Novosibirsk : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Perm : Teva Investigational Site 50127 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Pyatigorsk : Investigational Site Number 6010

Patients are needed to participate in a clinical research study evaluating alemtuzumab GZ402673 for the treatment of Relapsing Remitting Multiple Sclerosis

Rostov-on-Don : Teva Investigational Site 50143 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Saint Petersburg : Teva Investigational Site 50126 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Saint Petersburg : Teva Investigational Site 50140 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Saint-Petersburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Saint-Petersburg : Investigational Site Number 6008

Patients are needed to participate in a clinical research study evaluating alemtuzumab GZ402673 for the treatment of Relapsing Remitting Multiple Sclerosis

Saint-Petersburg : Investigational Site Number 6004

Patients are needed to participate in a clinical research study evaluating alemtuzumab GZ402673 for the treatment of Relapsing Remitting Multiple Sclerosis

Samara : Investigational Site Number 6013

Patients are needed to participate in a clinical research study evaluating alemtuzumab GZ402673 for the treatment of Relapsing Remitting Multiple Sclerosis

Samara : Teva Investigational Site 50138 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Saratov : Teva Investigational Site 50135 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Smolensk : Teva Investigational Site 50136 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

St. Petersburg : Novartis Investigative Site

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

St. Petersburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

St. Petersburg : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

St. Petersburg : Teva Investigational Site 50137 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tomsk : Teva Investigational Site 50125 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Tyumen : Teva Investigational Site 50139 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Ufa : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Ufa : Investigational Site Number 6016

Patients are needed to participate in a clinical research study evaluating alemtuzumab GZ402673 for the treatment of Relapsing Remitting Multiple Sclerosis

Ufa : Teva Investigational Site 50134 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Volgograd : Teva Investigational Site 50132 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Yaroslavl : Novartis Investigative Site

A Phase 3 clinical study for patients with Secondary Progressive Multiple Sclerosis

Yaroslavl : Teva Investigational Site 50142 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Saudi Arabia

Many Locations :

Patients are needed to participate in a clinical research study of Interferon beta-1b (Betaseron, BAY86-5046) to evaluate Multiple Sclerosis

Serbia

Belgrade : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Belgrade : Research Site

Patients are needed to participate in a clinical research study evaluating dimethyl fumarate and Interferon β-1a for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Belgrade : Teva Investigational Site 61027 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Belgrade : Teva Investigational Site 61025 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Belgrade : Teva Investigational Site 61024 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Cacak : Teva Investigational Site 61018 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Kragujevac : Teva Investigational Site 61015 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Nis : Teva Investigational Site 61014 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Sombar : Teva Investigational Site 61019 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)

Subotica : Teva Investigational Site 61016 Updated

Patients are needed to participate in a clinical research study evaluating Laquinimod 0.6 mg, Matching Placebo and Laquinimod 1.2 mg for the treatment of Multiple Sclerosis (MS)